Stockhead on MSN1h
Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure
One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...
Opthea’s flagship clinical trial has failed, with the biotech’s solvency now on the line
Biotechnology firm Opthea has warned investors its solvency is in question after the failure of a major clinical trial into ...